Clinical Trial Update: Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update for Type II Collagen (CII) APL A12 in rheumatoid arthritis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Type II Collagen (CII) APL A12 (Type II Collagen (CII) APL A12)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2019-03-19